MHS
TEVA icon

M Holdings Securities’s Teva Pharmaceuticals TEVA Stock Holding History

M Holdings Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,925
Closed -$504K – 268
2026
Q1 		$504K Buy
15,925
+27
+0.2% +$869 0.03% 252
2025
Q4 		$496K Buy
15,898
+4,180
+36% +$103K 0.04% 248
2025
Q3 		$237K Buy
+11,718
New +$206K 0.05% 87
2021
Q2 		– Sell
-13,167
Closed -$152K – 447
2021
Q1 		$152K Buy
+13,167
New +$151K 0.01% 476
2018
Q1 		– Sell
-13,050
Closed -$247K – 337
2017
Q4 		$247K Sell
13,050
-15,232
-54% -$229K 0.07% 269
2017
Q3 		$498K Buy
28,282
+5,425
+24% +$122K 0.16% 180
2017
Q2 		$759K Buy
22,857
+4,403
+24% +$136K 0.26% 106
2017
Q1 		$592K Buy
18,454
+4,902
+36% +$167K 0.23% 124
2016
Q4 		$491K Buy
+13,552
New +$541K 0.17% 137
2014
Q4 		– Sell
-1,020
Closed -$24K – 409
2014
Q3 		$24K Buy
+1,020
New +$54K 0.01% 495

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

M Holdings Securities's TEVA Position: Q2 2026 in Review

M Holdings Securities sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 15,925 shares — an estimated $504K sold.

M Holdings Securities first reported a position in TEVA in Q3 2014 and held it in 10 quarters. The position peaked at $759K in Q2 2017. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • M Holdings Securities reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • M Holdings Securities sold 15,925 Teva Pharmaceuticals shares in Q2 2026, an estimated $504K.
  • M Holdings Securities first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 10 quarters.
  • M Holdings Securities's Teva Pharmaceuticals position peaked at $759K in Q2 2017.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on M Holdings Securities's 13F filing for Q2 2026, filed 11 Aug 2026.